- Report
- November 2025
- 286 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 364 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 177 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 371 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 272 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 389 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 290 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 392 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 376 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 370 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 273 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 177 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 467 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 277 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 366 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 373 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 285 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 487 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more